May 13, 2022
With the backing of new laws, retail pharmacists have considerable freedom to switch patients to FDA approved interchangeable biosimilars. While most are willing to use that freedom, according to a new report, unanswered questions remain.
April 29, 2022
Treating patients with rheumatic diseases often involves using biologic medications, including biosimilars.
April 27, 2022
Biologic drugs, including biosimilars, are increasing the number of effective treatments for rheumatic diseases. Biologics are derived from living organisms,…
January 18, 2022
In some cases, patients switch between using similar medications without thinking twice. Aspirin and ibuprofen, for example, are both over-the-counter medications for treating minor pain. But not every swap is as easy to understand.
December 17, 2021
The sixth annual National Policy & Advocacy Summit on Biologics brought together healthcare providers, policy experts, patient advocates and other…
August 26, 2021
Injecting a syringe of an unapproved treatment into a patient’s eyeball would be a nightmare scenario for most ophthalmologists. But that is what many major insurance companies are now suggesting doctors do.
August 11, 2021
Health care in the United States has quietly turned a big corner. Just as the FDA approved its first interchangeable biosimilar, Oklahoma became the 50th and final state where pharmacists can substitute these lower-cost versions of biologic drugs.
July 13, 2021
I know some people who are brand loyal because they are hesitant to change. I, however, am not one of them. And I take that approach in prescribing biologics and biosimilars for my patients, too.
July 9, 2021
The admonition to the Institute for Clinical and Economic Review’s Beacon Hill economists should be quite simple: “Stay in your lane.”
June 24, 2021
Biosimilars are increasing the number of safe, effective treatments for cancer.